Company CVAbout Albert David Ltd 
Albert David Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Albert David Limited (ADL) was incorporated in 1938 at Kolkata. The Company belongs to a renowned industrial house of Kolkata, the "Kothari Group". Its specialised Kolkata manufacturing facility serves as the global hub for Placentrex production. The Company's principal business is manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export.
Company Coordinates
Company Details
D Block 3rd Flr Gillander Hous, Netaji Subhas Road Kolkata West Bengal : 700001
Registrar Details
Maheshwari Datamatics Pvt Ltd , 6 Mangoe Lane , 2nd Floor, Calcutta
Capital StructureCapital Structure
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
No Details Available.
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 1 Schemes (0.01%)
FIIs
Held by 4 FIIs (0.57%)
Promoter with highest holding
Kothari Investment And Industries Private Limited (41.36%)
Highest Public shareholder
General Insurance Corporation Of India (1.61%)
Individual Investors Holdings
28.05%
Board of Directors
Management
Designation
Remuneration
A K Kothari
Executive Chairman
2.09 cr
Hemal Kampani
Independent Director
3.95 lacs
Rajiv Singhi
Independent Director
3.85 lacs
Prabhawati Devi Kothari
Director
2.95 lacs
Arindam Sarkar
Independent Director
2.25 lacs
Shirish Gundopant Belapure
Independent Director
2.8 lacs
Monjori Mitra
Independent Director
1.85 lacs
Anand Vardhan Kothari
Director
1.75 lacs
A B Chakrabarty
Company Sec. & Compli. Officer
0
U. M. Kunte
Managing Director & CEO
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
86 Cr
(Quarterly Results - Mar 2026)
Net Profit:
-21 Cr
Pharmaceuticals & Biotechnology
INR 393 Cr (Micro Cap)
NA (Loss Making)
37
0.73%
-0.59
-0.38%
1.00
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
